Why did KPL.BO stock spike after hours on 13 Feb 2026?

The after-hours spike followed strong earnings metrics (EPS **47.28**) and heavy volume **182,279** shares. Positive technical momentum (RSI **69.16**) and relative valuation versus sector peers attracted buyers, pushing KPL.BO stock higher in BSE trading.

What are the key valuation metrics for Kwality Pharmaceuticals (KPL.BO)?

Key valuation figures: **PE 28.81**, **P/S 3.34**, **P/B 4.87**, market cap **INR 14,132,381,676.00**. Return on equity is **18.58%** and debt/equity is **0.38**, showing profitable operations with moderate leverage.

What price targets and forecasts does Meyka AI show for KPL.BO stock?

Meyka AI's forecast model projects a yearly figure of **INR 1,112.81** (implied **-22.26%**) and a five-year figure of **INR 1,637.68** (implied **+14.44%**) versus the current **INR 1,431.20**. Forecasts are model-based projections and not guarantees.

Should I trade KPL.BO stock now after the rally?

After-hours momentum favors short-term traders, but indicators suggest overbought conditions. Consider tight risk controls, watch volume for continuation, and evaluate fundamentals such as cash flow before adding KPL.BO stock to a long-term portfolio.

IN Stocks

KPL.BO Kwality Pharmaceuticals BSE +24.72% 13 Feb 2026 after hours: top gainer

ByDanny Kontos February 13, 2026February 13, 2026

KPL.BO stock surged 24.72% in after-hours trade on 13 Feb 2026, closing at INR 1,431.20 on the BSE. The move came with heavy volume of 182,279 shares versus an average of 16,373, signalling strong buying interest. Key fundamentals show EPS 47.28 and PE 28.81, while technicals (RSI 69.16) point to robust momentum. In this after-hours top-gainers note we break down what moved Kwality Pharmaceuticals Limited (KPL.BO), the valuation trade-offs, and how short-term momentum compares with longer-term Meyka forecasts and sector context.